Jacareubin Derivatives Increase Their Anti-Allergic Activity

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Immunology

Background:

• Xanthones, including jacareubin, exhibit anti-allergic properties through incompletely understood mechanisms.
• Understanding the structure-activity relationship (SAR) of jacareubin is crucial for developing new anti-allergic and anti-inflammatory agents.

Purpose of the Study:

• To investigate the SAR of jacareubin and its derivatives (xanthone V, peracetylated, and permethylated forms).
• To evaluate the anti-allergic and anti-inflammatory effects of these compounds using in vitro and in vivo models.

Main Methods:

• In vitro assays using bone marrow-derived mast cells (BMMCs) to assess inhibition of IgE/Antigen-induced degranulation, myeloperoxidase (MPO), and xanthine oxidase (XO) activation.
• In vivo studies including passive cutaneous anaphylaxis (PCA) and TPA-induced ear edema models.
• Molecular docking to support XO inhibition findings.

Main Results:

• Permethylated jacareubin (2b) showed superior inhibition of BMMC degranulation compared to jacareubin.
• The fourth cyclized ring of jacareubin is essential for anti-allergic efficacy, as indicated by reduced activity in xanthone V (1).
• Hydroxyl groups are critical for MPO inhibition, and jacareubin uniquely inhibited XO, confirmed by molecular docking.

Conclusions:

• Jacareubin's structure, particularly its fourth cyclized ring and hydroxyl groups, is vital for its anti-allergic and anti-inflammatory activities.
• Jacareubin acts as a multi-target scaffold, demonstrating potential for developing novel treatments for inflammatory and allergic conditions.